Lista de obras - Rebecca J Cox - Dominio Público Uruguay

A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.

artículo científico publicado en 2009

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine

artículo científico publicado en 2009

A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.

artículo científico publicado en 2009

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

artículo científico publicado en 2012

A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.

artículo científico publicado en 2012

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans ⬇️

artículo científico publicado en 2014

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers ⬇️

artículo científico publicado el 27 de octubre de 2010

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.

artículo científico publicado en 2017

Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination

artículo científico publicado en 2016

Correlates of protection to influenza virus, where do we go from here?

artículo científico publicado en 2013

Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination

artículo científico publicado en 2016

Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy

artículo científico publicado en 2017

Divergent H7 immunogens offer protection from H7N9 virus challenge.

artículo científico publicado en 2014

Epitope specific T-cell responses against influenza A in a healthy population.

artículo científico publicado en 2015

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

artículo científico publicado el 22 de agosto de 2011

Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination

artículo científico publicado en 2019

High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia

artículo científico publicado en 2017

Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies

artículo científico publicado en 2016

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.

artículo científico publicado en 2014

Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.

artículo científico publicado en 2018

Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.

artículo científico publicado en 2015

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

artículo científico publicado en 2014

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines

artículo científico publicado en 2015

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

artículo científico publicado en 2017

Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice.

artículo científico publicado en 2009

Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge

scientific article (publication date: 2014)

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice ⬇️

artículo científico publicado el 18 de mayo de 2011

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.

artículo científico publicado en 2015

Lars R. Haaheim PhD (1945–2011).

artículo científico publicado en 2011

Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.

artículo científico publicado en 2014

Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018

artículo científico publicado en 2019

Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.

artículo científico publicado en 2015

Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.

artículo científico publicado en 2014

Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

artículo científico publicado en 2011

Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines

artículo científico publicado en 2020

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice

artículo científico publicado en 2017

Not just antibodies: B cells and T cells mediate immunity to COVID-19

artículo científico publicado en 2020

Novel activities of safe-in-human broad-spectrum antiviral agents.

artículo científico publicado en 2018

Pandemic Influenza Vaccines – The Challenges ⬇️

artículo científico publicado el 3 de diciembre de 2009

Pandemic influenza vaccine development: time is of the essence

article

Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations.

artículo científico publicado en 2015

Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study

artículo científico publicado en 2016

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.

artículo científico publicado en 2014

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains

artículo científico publicado en 2015

T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome

artículo científico publicado en 2018

T-helper 1 cells elicited by H5N1 vaccination predict seroprotection

artículo científico publicado en 2012

The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines

artículo científico publicado en 2013

The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine

artículo científico publicado en 2015

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

artículo científico publicado en 2012

The influence of tonsillectomy on total serum antibody levels

artículo científico publicado en 2014

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine

artículo científico publicado en 2011

The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.

artículo científico

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

artículo científico publicado en 2015

Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses

artículo científico publicado en 2015

Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia

artículo científico publicado en 2019

Lista de obras de Rebecca J Cox

A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine

A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans ⬇️

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers ⬇️

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.

Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination

Correlates of protection to influenza virus, where do we go from here?

Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination

Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Epitope specific T-cell responses against influenza A in a healthy population.

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination

High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia

Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.

Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.

Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice.

Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice ⬇️

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.

Lars R. Haaheim PhD (1945–2011).

Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.

Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018

Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.

Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.

Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice

Not just antibodies: B cells and T cells mediate immunity to COVID-19

Novel activities of safe-in-human broad-spectrum antiviral agents.

Pandemic Influenza Vaccines – The Challenges ⬇️

Pandemic influenza vaccine development: time is of the essence

Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations.

Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains

T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome

T-helper 1 cells elicited by H5N1 vaccination predict seroprotection

The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines

The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

The influence of tonsillectomy on total serum antibody levels

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine

The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses

Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia